Focus on Innovation:
Arthroflex® Offers High Performance Solution for Soft Tissue Repair
 LifeNet Health offers a superior acellular bio-implant that leads the market in strength, safety and performance. ArthroFlex® is an acellular dermal extracellular matrix intended for supplemental support and covering for soft tissue repair. Surgeons prefer ArthroFlex due to:
-
Strength: Elastin and collagen provide unparalleled strength for supplemental support and covering for soft tissue repair.
-
Safety: MATRACELL technology removes donor DNA from the dermal matrix, ensuring a biocompatible scaffold to facilitate repair.
-
Performance: An intact acellular matrix of collagen, elastin and growth factors provides a clean scaffold intended for supplemental support and covering for soft tissue repair.
MATRACELL, a patented and validated process by LifeNet Health, renders the ArthroFlex allograft dermis acellular, without compromising biomechanical or biochemical properties. This process allows the matrix to retain its growth factors, native collagen scaffold, and elastin, which are required for healing. Matracell technology offers the following advantages:
-
Short processing time reduces the opportunity for water mediated lysis of the natural collagen and elastin scaffold
-
Utilizes multiple agents to provide for comprehensive tissue disinfection
-
Does not utilize animal-derived reagents
-
Uses a validated DNA assessment method, able to detect as little as one nanogram (ng/mL) of nucleic acid to ensure the tissue has been decellularized
Advantages of ArthroFlex High Performance Extracellular Matrix
-
> 97% DNA Removed making ArthroFlex Biocompatible
-
Intact Acellular Extracellular Matrix allows for product that retains growth factors, elastin and native collagen scaffold
-
Room Temperature Storage (15° - 30° C) Results in Excellent Handling and Minimal Prep Time
-
Sterile with 10-6 SAL (Sterility Assurance Level)
Quick Facts About Allograft Bio-Implants Used in Spine Surgery
Bone is the most commonly transplanted tissue in the U.S. second only to blood.
Not all allograft bone used for spinal fusion has the same sterility level as medical devices. It depends on the tissue bank.
Additional material required to fill a synthetic cage can raise the total cost of the implant by 50% or more.
While the patient's own bone is considered the "gold standard" for achieving fusion, often the pain and risk of a second surgical site outweighs the benefits.
New technological advances allow grafts to be stored at ambient temperature but in the same hydrated state as frozen grafts. The result is similar mechanical properties without the need for special storage facilities.
Want to learn more and receive continuing education credits? Contact your local LifeNet Health Bio-Implant Specialist or visit http://www.accesslifenethealth.org/service/education
|
